ROHTO Redness Relief, Cool, Redness Reliever, Lubricant Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (1...
FDA Drug Recall #D-1041-2014 — Class II — January 16, 2014
Recall Summary
| Recall Number | D-1041-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 16, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | The Mentholatum Co. |
| Location | Orchard Park, NY |
| Product Type | Drugs |
Product Description
ROHTO Redness Relief, Cool, Redness Reliever, Lubricant Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (13 mL). UPC 3 10742 01074 9, Manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. for The Mentholatum Company, Orchard Park, NY 14127. Made in Vietnam.
Reason for Recall
Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.
Distribution Pattern
Nationwide and Puerto Rico
Lot / Code Information
Stock No: 1074; Case UPC: 3 10742 81074 (5); Item UPC 3 10742 01074 9
Other Recalls from The Mentholatum Co.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0018-2016 | Class II | WellPatch¿ Capsaicin Pain Relief Patch, 0.025% ... | Sep 17, 2015 |
| D-1040-2014 | Class II | ROHTO Cooling Eye Drops, Itch Relief, Soothes I... | Jan 16, 2014 |
| D-1039-2014 | Class II | ROHTO Dry Eye, hydra, Lubricant Eye Drops, Ster... | Jan 16, 2014 |
| D-1037-2014 | Class II | ROHTO Redness Relief, arctic, Redness Reliever,... | Jan 16, 2014 |
| D-1038-2014 | Class II | ROHTO Redness Relief, ice, Redness Reliever, Lu... | Jan 16, 2014 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.